How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
Artificial intelligence is no longer something healthcare and life sciences teams are testing on the side. For healthcare and life sciences organizations, the question is how teams can adopt new capabilities without sacrificing rigor, privacy and tru...